ESC 365 - Assessing risk in pulmonary arterial hypertension – Why it is so important.

Open Access

Assessing risk in pulmonary arterial hypertension – Why it is so important.

Session: Therapies and strategies – Stay ahead in pulmonary arterial hypertension (Volume 1)

Topic: Chronic pulmonary hypertension

Speaker: Doctor S. Gibbs (London, GB)

Sponsored by Actelion Pharmaceuticals Ltd

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Simon Gibbs

National Heart and Lung Institute Imperial College, London (United Kingdom of Great Britain & Northern Ireland)

9 presentations

0 follower

3 more presentations in this session

Introduction - Therapies and strategies – Stay ahead in pulmonary arterial hypertension (Volume 1).

Speaker: Professor A. Torbicki (Otwock, PL)

Dual oral combination – Why it is so relevant.

Speaker: Professor N. Galie (Bologna, IT)

Panel discussion - Therapies and strategies – Stay ahead in pulmonary arterial hypertension (Volume 1).

Speaker: Professor I. Lang (Vienna, AT)

Access the full session

Therapies and strategies – Stay ahead in pulmonary arterial hypertension (Volume 1)

Speakers: Doctor S. Gibbs, Professor A. Torbicki, Professor N. Galie, Professor I. Lang

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources